Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score‐matched analysis of US nationwide inpatient sample 2016–2018

Objectives The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidn...

Full description

Saved in:
Bibliographic Details
Published inJournal of digestive diseases Vol. 24; no. 11; pp. 572 - 583
Main Authors Zheng, Wei Wei, Zhou, Quan, Xue, Meng Li, Yu, Xing, Chen, Jin Tong, Ao, Lu, Wang, Cheng Dang
Format Journal Article
LanguageEnglish
Published Melbourne Wiley Publishing Asia Pty Ltd 01.11.2023
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1751-2972
1751-2980
1751-2980
DOI10.1111/1751-2980.13233

Cover

Abstract Objectives The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD). Methods Data of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016–2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD‐10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions. Results Three cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non‐IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08–2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24–1.38), CKD at any stage (aOR 1.28, 95% CI 1.24–1.32), and moderate‐to‐severe CKD (aOR 1.22, 95% CI 1.17–1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions. Conclusions Patients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD compared to non‐IBD individuals. We assessed the relationship between inflammatory bowel disease (IBD), nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD) using a large, nationally representative U.S. database. This extensive epidemiological study indicates that individuals with Crohn's disease (CD) are particularly prone to having nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD.
AbstractList ObjectivesThe incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD).MethodsData of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016–2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD‐10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions.ResultsThree cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non‐IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08–2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24–1.38), CKD at any stage (aOR 1.28, 95% CI 1.24–1.32), and moderate‐to‐severe CKD (aOR 1.22, 95% CI 1.17–1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions.ConclusionsPatients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD compared to non‐IBD individuals.
Objectives The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD). Methods Data of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016–2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD‐10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions. Results Three cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non‐IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08–2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24–1.38), CKD at any stage (aOR 1.28, 95% CI 1.24–1.32), and moderate‐to‐severe CKD (aOR 1.22, 95% CI 1.17–1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions. Conclusions Patients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD compared to non‐IBD individuals. We assessed the relationship between inflammatory bowel disease (IBD), nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD) using a large, nationally representative U.S. database. This extensive epidemiological study indicates that individuals with Crohn's disease (CD) are particularly prone to having nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate‐to‐severe CKD.
The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD).OBJECTIVESThe incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD).Data of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016-2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD-10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions.METHODSData of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016-2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD-10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions.Three cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non-IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08-2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24-1.38), CKD at any stage (aOR 1.28, 95% CI 1.24-1.32), and moderate-to-severe CKD (aOR 1.22, 95% CI 1.17-1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions.RESULTSThree cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non-IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08-2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24-1.38), CKD at any stage (aOR 1.28, 95% CI 1.24-1.32), and moderate-to-severe CKD (aOR 1.22, 95% CI 1.17-1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions.Patients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate-to-severe CKD compared to non-IBD individuals.CONCLUSIONSPatients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate-to-severe CKD compared to non-IBD individuals.
The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally. We aimed to evaluate the potential association between IBD and nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease (CKD). Data of hospitalized adults ≥20 years of age were extracted from the U.S. National Inpatient Sample (NIS) during 2016-2018. Patients with UC, CD, or CKD were identified through the International Classification of Diseases, Tenth Revision (ICD-10) codes. Propensity score matching (PSM) analysis (1:1) was conducted to balance the characteristics between groups. Logistic regression analyses were performed to determine the relationships between UC or CD and kidney conditions. Three cohorts were included for analysis after PSM analysis. Cohorts 1, 2 and 3 contained 235 262 subjects (117 631 with CD or without IBD), 140 856 subjects (70 428 with UC or without IBD), and 139 098 subjects (69 549 with CD or UC), respectively. Multivariate analysis revealed that compared to non-IBD individuals, CD patients were significantly associated with greater odds for nephrolithiasis (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 2.08-2.43), tubulointerstitial nephritis (aOR 1.31, 95% CI 1.24-1.38), CKD at any stage (aOR 1.28, 95% CI 1.24-1.32), and moderate-to-severe CKD (aOR 1.22, 95% CI 1.17-1.26), while UC was associated with a higher rate of nephrolithiasis. Compared to UC, CD was associated with higher odds for all such kidney conditions. Patients with CD are more likely to have nephrolithiasis, tubulointerstitial nephritis, CKD at any stage, and moderate-to-severe CKD compared to non-IBD individuals.
Author Zheng, Wei Wei
Zhou, Quan
Ao, Lu
Chen, Jin Tong
Yu, Xing
Wang, Cheng Dang
Xue, Meng Li
Author_xml – sequence: 1
  givenname: Wei Wei
  orcidid: 0000-0002-9188-319X
  surname: Zheng
  fullname: Zheng, Wei Wei
  organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province
– sequence: 2
  givenname: Quan
  surname: Zhou
  fullname: Zhou, Quan
  organization: Fuzhou Center for Disease Control and Prevention Affiliated to Fujian Medical University
– sequence: 3
  givenname: Meng Li
  surname: Xue
  fullname: Xue, Meng Li
  organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province
– sequence: 4
  givenname: Xing
  surname: Yu
  fullname: Yu, Xing
  organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province
– sequence: 5
  givenname: Jin Tong
  surname: Chen
  fullname: Chen, Jin Tong
  organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province
– sequence: 6
  givenname: Lu
  surname: Ao
  fullname: Ao, Lu
  organization: Fujian Key Laboratory of Medical Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University
– sequence: 7
  givenname: Cheng Dang
  orcidid: 0000-0002-8765-7528
  surname: Wang
  fullname: Wang, Cheng Dang
  email: wangcdhl@fjmu.edu.cn
  organization: Clinical Research Center for Liver and Intestinal Diseases of Fujian Province
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37823607$$D View this record in MEDLINE/PubMed
BookMark eNqFUstu3CAURVWq5tGuu6uQuski0xiYAbu70SR9SJG6aLNGGF9rSDG4gDXyLp9Qqf-Vj8iXFM8ji0hV2dx74ZxzX5yiI-cdIPSWFB9IPpdELMiMVmUOGWXsBTp5ujl68gU9Rqcx3hXFgouSv0LHTJSU8UKcoIdljF4blYx3uIa0AXDYuNaqrlPJhxHXfgMWNyaCinCBHfTr4K1Ja6OiiRc4DfVgvXEJQkwmGWV3mOzmV-UarDPBGY1_msbBeJD6iJe4D74HF00acdQ-wOP975xVr6HJRGXHnAD7Ft9-x25b4cY0kKvrcwAu4ai63gKmBeGP93-yKV-jl62yEd7s7Rm6_XT9Y_VldvPt89fV8mammSBsVrGGkUIorhZ1PaelglZwzlhb0TmZK9VCuZiLumG04byuKipUlWfKOBO6BKDsDJ3vdHMHvwaISXYmarBWOfBDlLSc9MqKkQx9_wx654eQu8uoqqCCU0EnwXd71FB30Mg-mE6FUR42lQGLHUAHH2OAVmqTtkNJQRkrSSGnHyGnnctp_3L7IzLv8hnvIP1vxj7TxlgY_weXq6urHe8v-1_K5A
CitedBy_id crossref_primary_10_1080_15360288_2025_2481186
Cites_doi 10.3748/wjg.v20.i1.91
10.1371/journal.pone.0158765
10.1159/000188024
10.1007/978-981-13-8871-2_1
10.1093/ecco-jcc/jjv138
10.1016/j.cgh.2019.10.043
10.3389/fimmu.2019.00815
10.1053/j.ackd.2014.07.002
10.1016/j.pop.2020.08.001
10.1016/0895-4356(93)90103-8
10.3748/wjg.v24.i42.4798
10.1080/15548627.2019.1635384
10.1136/bmj.301.6755.818-b
10.1136/gut.40.6.761
10.1542/pir.2015-0110
10.1038/nrgastro.2015.150
10.2147/IJNRD.S45466
10.12659/MSM.936497
10.1093/gastro/gow015
10.1038/ki.2015.321
10.1016/j.pmedr.2023.102173
10.25122/jml-2018-0075
10.1038/s41581-018-0018-2
10.3390/nu12040944
10.1007/s00535-022-01903-6
10.1136/bmj.296.6634.1442
10.1007/s40257-022-00689-w
10.1371/journal.pone.0115947
10.1186/s12882‐021‐02358‐2
10.1023/A:1026629528233
10.1136/gut.38.1.99
10.1186/s40001‐022‐00687‐y
10.1136/bmj.e5287
10.1016/0016-5085(94)90066-3
10.1111/jgh.14356
10.1590/1806-9282.66.s1.3
10.15171/jnp.2017.42
10.2215/CJN.04660513
10.1046/j.1523-1755.2003.00725.x
10.1016/S0140-6736(17)32448-0
10.1136/gut.33.7.1006
10.1016/j.nefro.2016.05.008
10.1038/nrgastro.2017.88
10.1097/MIB.0000000000000963
10.1002/hsr2.1563
10.1093/ibd/izac140
10.1097/00005792-199209000-00001
10.1016/j.amjcard.2015.01.529
10.1001/jamacardio.2016.5131
10.1016/0016-5085(90)90839-S
10.1097/00004836-199701000-00008
10.3389/fcimb.2019.00206
10.1007/s10238-021-00766-0
10.1111/apt.15687
10.3390/ijerph19137933
10.1111/j.1365-2036.2006.03069.x
10.1007/s11255-020-02649-x
10.1136/gut.35.10.1493
ContentType Journal Article
Copyright 2023 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.
Copyright_xml – notice: 2023 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
DOI 10.1111/1751-2980.13233
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1751-2980
EndPage 583
ExternalDocumentID 37823607
10_1111_1751_2980_13233
CDD13233
Genre researchArticle
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: Open Project of Key Laboratories of Medical Bioinformatics in Colleges and Universities in Fujian Province
  funderid: FKLMB‐2020003
– fundername: 2021 Joint Funds for the Innovation of Science and Technology, Fujian Province
  funderid: 2021Y9119
– fundername: 2021 Joint Funds for the Innovation of Science and Technology, Fujian Province
  grantid: 2021Y9119
– fundername: Open Project of Key Laboratories of Medical Bioinformatics in Colleges and Universities in Fujian Province
  grantid: FKLMB-2020003
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
ID FETCH-LOGICAL-c3713-93d3107a6a5bb428aef76633f92414aafe8547bd32d66b9927a92983637c8ee23
IEDL.DBID DR2
ISSN 1751-2972
1751-2980
IngestDate Thu Jul 10 21:34:17 EDT 2025
Tue Oct 07 06:35:59 EDT 2025
Mon Jul 21 06:06:34 EDT 2025
Wed Oct 01 02:02:55 EDT 2025
Thu Apr 24 22:50:04 EDT 2025
Wed Jan 22 16:15:44 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords chronic kidney diseases
Crohn disease
ulcerative colitis
inflammatory bowel diseases
Language English
License 2023 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3713-93d3107a6a5bb428aef76633f92414aafe8547bd32d66b9927a92983637c8ee23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8765-7528
0000-0002-9188-319X
PMID 37823607
PQID 2902762722
PQPubID 2034585
PageCount 12
ParticipantIDs proquest_miscellaneous_2876638931
proquest_journals_2902762722
pubmed_primary_37823607
crossref_citationtrail_10_1111_1751_2980_13233
crossref_primary_10_1111_1751_2980_13233
wiley_primary_10_1111_1751_2980_13233_CDD13233
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2023
2023-11-00
2023-Nov
20231101
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: November 2023
PublicationDecade 2020
PublicationPlace Melbourne
PublicationPlace_xml – name: Melbourne
– name: Australia
– name: Richmond
PublicationTitle Journal of digestive diseases
PublicationTitleAlternate J Dig Dis
PublicationYear 2023
Publisher Wiley Publishing Asia Pty Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Publishing Asia Pty Ltd
– name: Wiley Subscription Services, Inc
References 2017; 5
2017; 6
2002; 15
1990; 98
1997; 40
2017; 2
2023; 33
1990; 301
2021; 22
2023; 6
2019; 10
2019; 12
1994; 67
2022; 23
2017; 390
2020; 16
1999; 44
2020; 12
2021; 72
1996; 38
2016; 37
2019; 1165
2013; 6
2022; 27
2022; 28
2014; 20
2020; 18
2018; 3
2017; 37
2023; 29
2006; 24
2020; 51
2020; 47
1994; 35
1988; 296
2014; 9
1994; 107
1996; 8
2016; 89
2015; 12
1993; 46
2019; 9
2019; 34
1997; 24
2015; 10
2016; 10
2012; 345
1992; 33
1992; 71
2016; 11
2018; 24
2021; 53
2015; 115
2017; 14
2005; 125
2015; 22
2022; 57
2020; 66
2003; 63
2018; 14
2022; 19
2016; 22
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_56_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_58_1
e_1_2_9_18_1
Kreisel W (e_1_2_9_29_1) 1996; 8
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_20_1
e_1_2_9_62_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_24_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_4_1
e_1_2_9_60_1
e_1_2_9_2_1
e_1_2_9_26_1
e_1_2_9_49_1
Ferreira SDC (e_1_2_9_54_1) 2018; 3
e_1_2_9_28_1
e_1_2_9_47_1
Mendoza JL (e_1_2_9_50_1) 2005; 125
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_51_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_61_1
e_1_2_9_46_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_7_1
e_1_2_9_5_1
Katsanos KT (e_1_2_9_21_1) 2002; 15
e_1_2_9_3_1
e_1_2_9_9_1
Adamowicz M (e_1_2_9_43_1) 2021; 72
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
References_xml – volume: 46
  start-page: 1075
  issue: 10
  year: 1993
  end-page: 1079
  article-title: Adapting a clinical comorbidity index for use with ICD‐9‐CM administrative data: differing perspectives
  publication-title: J Clin Epidemiol
– volume: 98
  start-page: 464
  issue: 2
  year: 1990
  end-page: 469
  article-title: A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody
  publication-title: Gastroenterology
– volume: 6
  start-page: 139
  year: 2013
  end-page: 142
  article-title: Nephrolithiasis in patients with inflammatory bowel disease in the community
  publication-title: Int J Nephrol Renovasc Dis
– volume: 35
  start-page: 1493
  issue: 10
  year: 1994
  end-page: 1496
  article-title: Mesalazine induced interstitial nephritis
  publication-title: Gut
– volume: 24
  start-page: 4798
  issue: 42
  year: 2018
  end-page: 4808
  article-title: Increased end‐stage renal disease risk in patients with inflammatory bowel disease: a nationwide population‐based study
  publication-title: World J Gastroenterol
– volume: 29
  start-page: 1306
  issue: 8
  year: 2023
  end-page: 1316
  article-title: Renal and urological disorders associated with inflammatory bowel disease
  publication-title: Inflamm Bowel Dis
– volume: 5
  start-page: 36
  issue: 1
  year: 2017
  end-page: 42
  article-title: Nationwide trends of hospital admissions for acute cholecystitis in the United States
  publication-title: Gastroenterol Rep (Oxf).
– volume: 51
  start-page: 870
  issue: 9
  year: 2020
  end-page: 879
  article-title: Tacrolimus induces short‐term but not long‐term clinical response in inflammatory bowel disease
  publication-title: Aliment Pharmacol Ther
– volume: 22
  start-page: 629
  issue: 4
  year: 2021
  end-page: 635
  article-title: Spectrum and prognosis of renal histopathological lesions in patients with inflammatory bowel disease: a cross‐sectional study from a single center in China
  publication-title: Clin Exp Med
– volume: 2
  start-page: 250
  issue: 3
  year: 2017
  end-page: 258
  article-title: Management and outcomes of ST‐segment elevation myocardial infarction in US renal transplant recipients
  publication-title: JAMA Cardiol
– volume: 6
  issue: 9
  year: 2023
  article-title: Joint modeling on serum creatinine and time to end stage of renal disease for chronic kidney disease patients under treatment at the University of Gondar Referral Hospital
  publication-title: Health Sci Rep.
– volume: 8
  start-page: 461
  issue: 5
  year: 1996
  end-page: 468
  article-title: Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease
  publication-title: Eur J Gastroenterol Hepatol
– volume: 19
  start-page: 7933
  issue: 13
  year: 2022
  article-title: Validity of diagnostic algorithms for inflammatory bowel disease in Japanese hospital claims data
  publication-title: Int J Environ Res Public Health.
– volume: 34
  start-page: 154
  issue: 1
  year: 2019
  end-page: 161
  article-title: Altered uric acid metabolism in isolated colonic Crohn's disease but not ulcerative colitis
  publication-title: J Gastroenterol Hepatol
– volume: 24
  start-page: 37
  issue: 1
  year: 1997
  end-page: 39
  article-title: Nephrotic syndrome from 5‐ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis
  publication-title: J Clin Gastroenterol
– volume: 40
  start-page: 761
  issue: 6
  year: 1997
  end-page: 766
  article-title: Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate
  publication-title: Gut
– volume: 67
  start-page: 481
  issue: 4
  year: 1994
  end-page: 482
  article-title: Interstitial nephritis associated with 5‐aminosalicylic acid
  publication-title: Nephron
– volume: 115
  start-page: 1033
  issue: 8
  year: 2015
  end-page: 1041
  article-title: Trends in management and outcomes of ST‐elevation myocardial infarction in patients with end‐stage renal disease in the United States
  publication-title: Am J Cardiol
– volume: 18
  start-page: 2262
  issue: 10
  year: 2020
  end-page: 2268
  article-title: Inflammatory bowel diseases are associated with an increased risk for chronic kidney disease, which decreases with age
  publication-title: Clin Gastroenterol Hepatol
– volume: 47
  start-page: 585
  issue: 4
  year: 2020
  end-page: 595
  article-title: Chronic kidney disease
  publication-title: Prim Care
– volume: 12
  start-page: 720
  issue: 12
  year: 2015
  end-page: 727
  article-title: The global burden of IBD: from 2015 to 2025
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 296
  start-page: 1442
  issue: 6634
  year: 1988
  article-title: Nephrotic syndrome after treatment with 5‐aminosalicylic acid
  publication-title: Br Med J (Clin Res Ed)
– volume: 10
  start-page: 815
  year: 2019
  article-title: NFκB and kidney injury
  publication-title: Front Immunol
– volume: 390
  start-page: 2769
  issue: 10114
  year: 2017
  end-page: 2778
  article-title: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population‐based studies
  publication-title: Lancet
– volume: 33
  year: 2023
  article-title: Inflammatory bowel disease prevalence: surveillance data from the U.S
  publication-title: Prev Med Rep.
– volume: 37
  start-page: 337
  issue: 8
  year: 2016
  end-page: 347
  article-title: Inflammatory bowel disease
  publication-title: Pediatr Rev
– volume: 22
  start-page: 146
  issue: 1
  year: 2021
  article-title: Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature
  publication-title: BMC Nephrol
– volume: 20
  start-page: 91
  issue: 1
  year: 2014
  end-page: 99
  article-title: Inflammatory bowel disease: pathogenesis
  publication-title: World J Gastroenterol
– volume: 22
  start-page: 6
  issue: 1
  year: 2015
  end-page: 15
  article-title: Socioeconomic disparities in chronic kidney disease
  publication-title: Adv Chronic Kidney Dis
– volume: 38
  start-page: 99
  issue: 1
  year: 1996
  end-page: 103
  article-title: Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease
  publication-title: Gut
– volume: 89
  start-page: 185
  issue: 1
  year: 2016
  end-page: 192
  article-title: Assessing the risk of incident hypertension and chronic kidney disease after exposure to shock wave lithotripsy and ureteroscopy
  publication-title: Kidney Int
– volume: 15
  start-page: 41
  issue: 1
  year: 2002
  end-page: 52
  article-title: The kidneys in inflammatory bowel disease
  publication-title: Ann Gastroenterol
– volume: 24
  start-page: 2
  issue: Suppl 1
  year: 2006
  end-page: 9
  article-title: Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence
  publication-title: Aliment Pharmacol Ther
– volume: 63
  start-page: 255
  issue: 1
  year: 2003
  end-page: 265
  article-title: Urine stone risk factors in nephrolithiasis patients with and without bowel disease
  publication-title: Kidney Int
– volume: 1165
  start-page: 3
  year: 2019
  end-page: 15
  article-title: Prevalence and disease burden of chronic kidney disease
  publication-title: Adv Exp Med Biol
– volume: 44
  start-page: 1
  issue: 1
  year: 1999
  end-page: 13
  article-title: Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis
  publication-title: Dig Dis Sci
– volume: 72
  start-page: 529
  issue: 4
  year: 2021
  end-page: 535
  article-title: 5‐aminosalicylic acid inhibits the expression of oncomiRs and pro‐inflammatory microRNAs: an in vitro study
  publication-title: J Physiol Pharmacol
– volume: 6
  start-page: 264
  issue: 3
  year: 2017
  end-page: 269
  article-title: Nephrolithiasis as a common urinary system manifestation of inflammatory bowel diseases; a clinical review and meta‐analysis
  publication-title: J Nephropathol
– volume: 9
  start-page: 265
  issue: 2
  year: 2014
  end-page: 270
  article-title: The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease
  publication-title: Clin J Am Soc Nephrol
– volume: 14
  start-page: 573
  issue: 10
  year: 2017
  end-page: 584
  article-title: Gut microbiota and IBD: causation or correlation?
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 12
  start-page: 113
  issue: 2
  year: 2019
  end-page: 122
  article-title: A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease
  publication-title: J Med Life
– volume: 27
  start-page: 61
  issue: 1
  year: 2022
  article-title: 5‐ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review
  publication-title: Eur J Med Res
– volume: 16
  start-page: 38
  issue: 1
  year: 2020
  end-page: 51
  article-title: New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD
  publication-title: Autophagy
– volume: 10
  issue: 1
  year: 2015
  article-title: The restrained expression of NF‐kB in renal tissue ameliorates folic acid induced acute kidney injury in mice
  publication-title: PLoS One
– volume: 11
  issue: 7
  year: 2016
  article-title: Global prevalence of chronic kidney disease – a systematic review and meta‐analysis
  publication-title: PLoS One
– volume: 22
  start-page: 2902
  issue: 12
  year: 2016
  end-page: 2906
  article-title: Crohn's disease is associated with the risk for thyroid cancer
  publication-title: Inflamm Bowel Dis
– volume: 9
  start-page: 206
  year: 2019
  article-title: Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease
  publication-title: Front Cell Infect Microbiol
– volume: 66
  start-page: s03
  issue: Suppl 1
  year: 2020
  end-page: s09
  article-title: Chronic kidney disease
  publication-title: Rev Assoc Med Bras (1992)
– volume: 107
  start-page: 103
  issue: 1
  year: 1994
  end-page: 108
  article-title: A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody
  publication-title: Gastroenterology
– volume: 71
  start-page: 261
  issue: 5
  year: 1992
  end-page: 270
  article-title: Amyloidosis and inflammatory bowel disease. A 50‐year experience with 25 patients
  publication-title: Medicine (Baltimore)
– volume: 12
  start-page: 944
  issue: 4
  year: 2020
  article-title: Nutrition, IBD and gut microbiota: a review
  publication-title: Nutrients
– volume: 28
  year: 2022
  article-title: Renal manifestations in inflammatory bowel disease: a cohort study during the biologic era
  publication-title: Med Sci Monit
– volume: 14
  start-page: 442
  issue: 7
  year: 2018
  end-page: 456
  article-title: The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
  publication-title: Nat Rev Nephrol
– volume: 345
  year: 2012
  article-title: Kidney stones and kidney function loss: a cohort study
  publication-title: BMJ
– volume: 33
  start-page: 1006
  issue: 7
  year: 1992
  end-page: 1007
  article-title: Sulphasalazine induced renal failure
  publication-title: Gut
– volume: 57
  start-page: 619
  issue: 9
  year: 2022
  end-page: 629
  article-title: Renal manifestations in inflammatory bowel disease: a systematic review
  publication-title: J Gastroenterol
– volume: 23
  start-page: 481
  issue: 4
  year: 2022
  end-page: 497
  article-title: Cutaneous manifestations of inflammatory bowel disease: a basic overview
  publication-title: Am J Clin Dermatol
– volume: 37
  start-page: 9
  issue: 1
  year: 2017
  end-page: 19
  article-title: Gut microbiota in chronic kidney disease
  publication-title: Nefrologia
– volume: 3
  start-page: 4
  issue: 1
  year: 2018
  end-page: 11
  article-title: Extraintestinal manifestations of inflammatory bowel disease: clinical aspects and pathogenesis
  publication-title: J Gastroenterol Dig Dis
– volume: 53
  start-page: 205
  issue: 2
  year: 2021
  end-page: 209
  article-title: Urolithiasis in complicated inflammatory bowel disease: a comprehensive analysis of urine profile and stone composition
  publication-title: Int Urol Nephrol
– volume: 301
  start-page: 818
  issue: 6755
  year: 1990
  article-title: Nephrotic syndrome associated with sulphasalazine
  publication-title: BMJ
– volume: 125
  start-page: 297
  issue: 8
  year: 2005
  end-page: 300
  article-title: Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis
  publication-title: Med Clin (Barc)
– volume: 10
  start-page: 226
  issue: 2
  year: 2016
  end-page: 235
  article-title: Renal involvement in inflammatory bowel diseases
  publication-title: J Crohns Colitis
– ident: e_1_2_9_3_1
  doi: 10.3748/wjg.v20.i1.91
– ident: e_1_2_9_10_1
  doi: 10.1371/journal.pone.0158765
– ident: e_1_2_9_32_1
  doi: 10.1159/000188024
– ident: e_1_2_9_11_1
  doi: 10.1007/978-981-13-8871-2_1
– ident: e_1_2_9_49_1
  doi: 10.1093/ecco-jcc/jjv138
– ident: e_1_2_9_39_1
  doi: 10.1016/j.cgh.2019.10.043
– ident: e_1_2_9_46_1
  doi: 10.3389/fimmu.2019.00815
– volume: 15
  start-page: 41
  issue: 1
  year: 2002
  ident: e_1_2_9_21_1
  article-title: The kidneys in inflammatory bowel disease
  publication-title: Ann Gastroenterol
– ident: e_1_2_9_12_1
  doi: 10.1053/j.ackd.2014.07.002
– ident: e_1_2_9_9_1
  doi: 10.1016/j.pop.2020.08.001
– ident: e_1_2_9_38_1
  doi: 10.1016/0895-4356(93)90103-8
– volume: 72
  start-page: 529
  issue: 4
  year: 2021
  ident: e_1_2_9_43_1
  article-title: 5‐aminosalicylic acid inhibits the expression of oncomiRs and pro‐inflammatory microRNAs: an in vitro study
  publication-title: J Physiol Pharmacol
– ident: e_1_2_9_41_1
  doi: 10.3748/wjg.v24.i42.4798
– volume: 3
  start-page: 4
  issue: 1
  year: 2018
  ident: e_1_2_9_54_1
  article-title: Extraintestinal manifestations of inflammatory bowel disease: clinical aspects and pathogenesis
  publication-title: J Gastroenterol Dig Dis
– ident: e_1_2_9_62_1
  doi: 10.1080/15548627.2019.1635384
– ident: e_1_2_9_16_1
  doi: 10.1136/bmj.301.6755.818-b
– ident: e_1_2_9_20_1
  doi: 10.1136/gut.40.6.761
– ident: e_1_2_9_2_1
  doi: 10.1542/pir.2015-0110
– ident: e_1_2_9_5_1
  doi: 10.1038/nrgastro.2015.150
– ident: e_1_2_9_25_1
  doi: 10.2147/IJNRD.S45466
– ident: e_1_2_9_14_1
  doi: 10.12659/MSM.936497
– ident: e_1_2_9_33_1
  doi: 10.1093/gastro/gow015
– ident: e_1_2_9_26_1
  doi: 10.1038/ki.2015.321
– ident: e_1_2_9_7_1
  doi: 10.1016/j.pmedr.2023.102173
– volume: 8
  start-page: 461
  issue: 5
  year: 1996
  ident: e_1_2_9_29_1
  article-title: Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease
  publication-title: Eur J Gastroenterol Hepatol
– ident: e_1_2_9_4_1
  doi: 10.25122/jml-2018-0075
– ident: e_1_2_9_61_1
  doi: 10.1038/s41581-018-0018-2
– ident: e_1_2_9_63_1
  doi: 10.3390/nu12040944
– ident: e_1_2_9_23_1
  doi: 10.1007/s00535-022-01903-6
– ident: e_1_2_9_19_1
  doi: 10.1136/bmj.296.6634.1442
– ident: e_1_2_9_48_1
  doi: 10.1007/s40257-022-00689-w
– ident: e_1_2_9_45_1
  doi: 10.1371/journal.pone.0115947
– ident: e_1_2_9_47_1
  doi: 10.1186/s12882‐021‐02358‐2
– ident: e_1_2_9_52_1
  doi: 10.1023/A:1026629528233
– ident: e_1_2_9_30_1
  doi: 10.1136/gut.38.1.99
– ident: e_1_2_9_42_1
  doi: 10.1186/s40001‐022‐00687‐y
– ident: e_1_2_9_24_1
  doi: 10.1136/bmj.e5287
– ident: e_1_2_9_51_1
  doi: 10.1016/0016-5085(94)90066-3
– ident: e_1_2_9_58_1
  doi: 10.1111/jgh.14356
– ident: e_1_2_9_8_1
  doi: 10.1590/1806-9282.66.s1.3
– ident: e_1_2_9_56_1
  doi: 10.15171/jnp.2017.42
– ident: e_1_2_9_15_1
  doi: 10.2215/CJN.04660513
– ident: e_1_2_9_27_1
  doi: 10.1046/j.1523-1755.2003.00725.x
– ident: e_1_2_9_6_1
  doi: 10.1016/S0140-6736(17)32448-0
– ident: e_1_2_9_17_1
  doi: 10.1136/gut.33.7.1006
– ident: e_1_2_9_59_1
  doi: 10.1016/j.nefro.2016.05.008
– ident: e_1_2_9_64_1
  doi: 10.1038/nrgastro.2017.88
– ident: e_1_2_9_35_1
  doi: 10.1097/MIB.0000000000000963
– ident: e_1_2_9_13_1
  doi: 10.1002/hsr2.1563
– ident: e_1_2_9_22_1
  doi: 10.1093/ibd/izac140
– ident: e_1_2_9_28_1
  doi: 10.1097/00005792-199209000-00001
– ident: e_1_2_9_36_1
  doi: 10.1016/j.amjcard.2015.01.529
– ident: e_1_2_9_37_1
  doi: 10.1001/jamacardio.2016.5131
– ident: e_1_2_9_53_1
  doi: 10.1016/0016-5085(90)90839-S
– ident: e_1_2_9_18_1
  doi: 10.1097/00004836-199701000-00008
– volume: 125
  start-page: 297
  issue: 8
  year: 2005
  ident: e_1_2_9_50_1
  article-title: Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis
  publication-title: Med Clin (Barc)
– ident: e_1_2_9_60_1
  doi: 10.3389/fcimb.2019.00206
– ident: e_1_2_9_40_1
  doi: 10.1007/s10238-021-00766-0
– ident: e_1_2_9_55_1
  doi: 10.1111/apt.15687
– ident: e_1_2_9_34_1
  doi: 10.3390/ijerph19137933
– ident: e_1_2_9_44_1
  doi: 10.1111/j.1365-2036.2006.03069.x
– ident: e_1_2_9_57_1
  doi: 10.1007/s11255-020-02649-x
– ident: e_1_2_9_31_1
  doi: 10.1136/gut.35.10.1493
SSID ssj0056786
Score 2.3464956
Snippet Objectives The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing...
The incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing globally....
ObjectivesThe incidence and prevalence of inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn's disease (CD), are increasing...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 572
SubjectTerms Adult
chronic kidney diseases
Colitis, Ulcerative - complications
Crohn disease
Crohn Disease - complications
Crohn Disease - epidemiology
Crohn's disease
Humans
Inflammatory bowel disease
Inflammatory bowel diseases
Inflammatory Bowel Diseases - complications
Inpatients
Intestine
Kidney diseases
Kidney stones
Multivariate analysis
Nephritis
Nephritis, Interstitial - complications
Nephritis, Interstitial - epidemiology
Nephrolithiasis
Nephrolithiasis - complications
Nephrolithiasis - epidemiology
Propensity Score
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - etiology
Retrospective Studies
Ulcerative colitis
Title Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score‐matched analysis of US nationwide inpatient sample 2016–2018
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1751-2980.13233
https://www.ncbi.nlm.nih.gov/pubmed/37823607
https://www.proquest.com/docview/2902762722
https://www.proquest.com/docview/2876638931
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: Academic Search Ultimate (EBSCOhost)
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1751-2980
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0056786
  issn: 1751-2972
  databaseCode: ABDBF
  dateStart: 20070301
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1751-2972
  databaseCode: DR2
  dateStart: 20000101
  customDbUrl:
  isFulltext: true
  eissn: 1751-2980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0056786
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NatwwEBYlh9BL_3-2TcsUeuhhvazlH8m9haQhBNJD24XejGRJdMnGDvGa0J7yCIW-Vx8iT5IZyTZJSimhl90FS2sZfaP5xjP6xNhbnskqrYSKimzuKM2YR4XjLuIG_ZnNdaW8HMPhx3x_kR58zYZqQtoLE_QhxhduZBl-vSYDV7q9YuTo9-KIF5KObuAJ6X3GSe6Dqk-jgFSGS7HfXxTaCt6L-1Atz43-1_3SH2TzOnf1zmfvPtPDsEPNydGsW-tZ9eOGouN_PdcDdq-nprAdsPSQ3bH1I7Z52CffH7PfV6YS-vouQIAipo59rh50c2ZX0Od8plBbRArV131bqnbZTmHd6W7VkELFKZUoIPRDG9JVmoKqDVRBqxeOlqa234e_eg_bcEJZg5oqSKAl6c2L8594V4ScwY5BWAUaB4vPEN5vni2NxdH1urHQKpJBBiQi-cX5L_yST9hi78OXnf2oPw4iqhIMpaMiMchFhcpVpjVGTco6gXwpcRhCxqlSzsosFdok3OS5LgouFHI_iaAQlbSWJ0_ZRt3U9jkDbaRJhbKFdFnqtJMmLvBD2UypBGnDhM0GMJRVr5VOR3asyiFmolkqaZZKP0sT9m7scBJkQv7edGtAV9mvFy1ennN0S4LzCXszXkZLp_SNqm3TYRtJj4v8Mp6wZwGV470SQQfXzwUO3GPrX4Mod3Z3_Y8Xt-3wkt3lyPPCdswttrE-7ewr5GVr_dqb3iVKdzBs
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELagSMCF_5-FAkbiwGGz2rWT2OFWtVQLdHuArtRbZMe2WHVJqmajCk59BCTei4fokzBjJ9G2CCHEZbNS7MSRv7G_8Yw_E_KKJbKIC6GiLBk7DDOmUeaYi5iB-cymulBejmG2n07n8fvD5HBtL0zQh-gX3NAy_HiNBo4L0mtWDhPfJGKZxLMbGOdXybU4BW8FidHHXkIqgcHY7zAKhQVr5X0wm-fSAy7OTL_RzYvs1U8_u7dJ0TU8ZJ0cjZqVHhXfLmk6_t-X3SG3WnZKtwKc7pIrtrxHrs_a-Pt98nOtN2mb4kUBowCrLz5cT3V1ape0DfsMaWkBLJhi93mh6kU9pKtGN8sKRSpOMEsB0B_KoLTSkKrS0CLI9dKjhSnt1-5Rb-gWPcbAQYlJJLRG9c3zs-_wVkCdgYpBW4VWjs4_0bDEebowFlrXSsfSWqESMgUukp6f_YCLfEDmu28PtqdReyJEVHDwpqOMG6CjQqUq0RocJ2WdAMrEHXiRk1gpZ2USC204M2mqs4wJBfRP8pSLQlrL-EOyUValfUyoNtLEQtlMuiR22kkzyeBH2UQpDsxhQEYdGvKilUvHUzuWeec2YS_l2Eu576UBed1XOA5KIX8uutnBK2-HjBpujxnMTIKxAXnZ3wZjxwiOKm3VQBmJnwsUczIgjwIs-3dxgWfXjwU03IPrb43It3d2_J8n_1rhBbkxPZjt5Xvv9j88JTcZ0L6wO3OTbKxOGvsMaNpKP_d2-AtMLDSN
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELagSBUXKH9loRQjceCwWe3aSexwq7pdlZ9WCFipt8iObbHqkqyajar21EdA4r36EH0SZuIk2hYhhLgkkWInjvyN53Nm_JmQ1yySWZgJFSTR0GGYMQ4Sx1zADPgzG-tM1XIMB4fx_jR8fxQdrayF8foQ3Q83tIx6vEYDtwvjVqwcHN8oYInEvRsY57fJnTBKJKb1jT93ElIRDMb1CiNfWLBG3gezeW484Lpn-o1uXmevtfuZ3CdZ23CfdXI8qJZ6kJ3f0HT8vy_bIPcadkp3PJwekFs2f0jWD5r4-yNyudKbtEnxooBRgNX3OlxPdXFq57QJ-_RpbgEsmGL3babKWdmny0pX8wJFKk4wSwHQ78ugtFKfqtzQzMv10uOZye1Z-6i3dIcuMHCQYxIJLVF98-riB7wVUGegotdWoYWj0y_U_-I8nRkLrWukY2mpUAmZAheJry5-wkk-JtPJ3tfd_aDZESLIOMymg4QboKNCxSrSGiZOyjoBlIk7mEWOQqWclVEotOHMxLFOEiYU0D_JYy4yaS3jT8haXuT2KaHaSBMKZRPpotBpJ80ogYOykVIcmEOPDFo0pFkjl467dszTdtqEvZRiL6V1L_XIm67CwiuF_LnoVguvtBkySrg9ZOCZBGM98qq7DcaOERyV26KCMhI_FyjmqEc2PSy7d3GBe9cPBTS8BtffGpHujsf1xbN_rfCSrH8aT9KP7w4_PCd3GbA-vzhzi6wtTyr7AljaUm_XZvgLq9g0EQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+inflammatory+bowel+disease%2C+nephrolithiasis%2C+tubulointerstitial+nephritis%2C+and+chronic+kidney+disease%3A+A+propensity+score%E2%80%90matched+analysis+of+US+nationwide+inpatient+sample+2016%E2%80%932018&rft.jtitle=Journal+of+digestive+diseases&rft.au=Wei+Wei+Zheng&rft.au=Zhou%2C+Quan&rft.au=Meng+Li+Xue&rft.au=Yu%2C+Xing&rft.date=2023-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1751-2972&rft.eissn=1751-2980&rft.volume=24&rft.issue=11&rft.spage=572&rft.epage=583&rft_id=info:doi/10.1111%2F1751-2980.13233&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1751-2972&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1751-2972&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1751-2972&client=summon